| Revenue growth | 77% YoY consolidated growth in FY26. |
|---|---|
| Margins | Consolidated EBITDA margin improved from 23% to 24% in FY26. |
| Demand visibility | Strong across Pharma, Food, and Automotive testing segments. |
| Management confidence | High; aiming to be leading global lab by 2031-32. |
Growth
FY26 Consolidated Revenue grew 77% YoY to ₹124.5 Cr; PAT surged 90% YoY to ₹14.6 Cr.
Outlook
FY27 guidance: 35-40% revenue growth, 25-26% EBITDA margins. Plans ₹63 Cr capex and new lab acquisitions.
Risks
Expansion into new regions and sectors may face competition and regulatory compliance hurdles across global markets.
Earnings Call filed with BSE, BSE: 544091. Summary written with AI assistance from the document.
Qualitek Labs Ltd: key numbers
- Share price
- ₹621.00
- Market cap
- ₹619.7 Cr
- Revenue (annual)
- ₹124.5 Cr
- Net profit (annual)
- ₹14.60 Cr
- P/E (TTM)
- 42.4×Sector 41.4×
- Promoter holding
- 56.46%
- FII holding
- 1.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Qualitek Labs Ltd
All →Qualitek Labs Annual General Meeting
Qualitek Labs Limited held its 8th Annual General Meeting on September 25, 2026. Shareholders approved financial statements, re-appointment of the MD, and material related party transactions.
Qualitek Labs Annual General Meeting
Qualitek Labs Ltd issued an EGM notice to seek shareholder approval for a preferential issuance of 3.86 lakh equity shares and 5.20 lakh convertible warrants.
- Value
- ₹46.98 Cr
Qualitek Labs Capital Structure Change
Qualitek Labs replaced one proposed allottee in its preferential issue. The number of shares for this allocation remains unchanged at 16,000.
Qualitek Labs Fund Raise of ₹46.98 Cr
Qualitek Labs will issue 3.86 lakh equity shares and 5.20 lakh fully convertible warrants on a preferential basis to raise capital for the company.
- Value
- ₹46.98 Cr
Qualitek Labs Board Meeting Date
Qualitek Labs has scheduled a Board Meeting for September 22, 2026, to consider a fund raising proposal. No specific amount or terms are disclosed yet.
Qualitek Labs Annual General Meeting
Qualitek Labs Limited has withdrawn Item No. 4 (regarding increased managerial remuneration) from its upcoming Annual General Meeting notice. Other AGM businesses remain unchanged.